These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 19912596)

  • 1. Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals.
    Xu S; Ross C; Raebel MA; Shetterly S; Blanchette C; Smith D
    Value Health; 2010; 13(2):273-7. PubMed ID: 19912596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On variance estimation of the inverse probability-of-treatment weighting estimator: A tutorial for different types of propensity score weights.
    Kostouraki A; Hajage D; Rachet B; Williamson EJ; Chauvet G; Belot A; Leyrat C
    Stat Med; 2024 Jun; 43(13):2672-2694. PubMed ID: 38622063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis.
    Austin PC
    Stat Med; 2016 Dec; 35(30):5642-5655. PubMed ID: 27549016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variance reduction in randomised trials by inverse probability weighting using the propensity score.
    Williamson EJ; Forbes A; White IR
    Stat Med; 2014 Feb; 33(5):721-37. PubMed ID: 24114884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Generalized Bootstrap Procedure of the Standard Error and Confidence Interval Estimation for Inverse Probability of Treatment Weighting.
    Li T; Lawson J
    Multivariate Behav Res; 2024; 59(2):251-265. PubMed ID: 37724449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of inverse probability weighting using the propensity score for baseline covariate adjustment in smaller population randomised controlled trials with a continuous outcome.
    Raad H; Cornelius V; Chan S; Williamson E; Cro S
    BMC Med Res Methodol; 2020 Mar; 20(1):70. PubMed ID: 32293286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The performance of different propensity-score methods for estimating differences in proportions (risk differences or absolute risk reductions) in observational studies.
    Austin PC
    Stat Med; 2010 Sep; 29(20):2137-48. PubMed ID: 20108233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing Extreme Propensity Scores in Estimating Counterfactual Survival Functions via the Overlap Weights.
    Cheng C; Li F; Thomas LE; Li FF
    Am J Epidemiol; 2022 May; 191(6):1140-1151. PubMed ID: 35238335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variance estimation of the risk difference when using propensity-score matching and weighting with time-to-event outcomes.
    Cafri G; Austin PC
    Pharm Stat; 2023; 22(5):880-902. PubMed ID: 37258420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The performance of marginal structural models for estimating risk differences and relative risks using weighted univariate generalized linear models.
    Austin PC
    Stat Methods Med Res; 2024 Jun; 33(6):1055-1068. PubMed ID: 38655786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies.
    Austin PC; Stuart EA
    Stat Med; 2015 Dec; 34(28):3661-79. PubMed ID: 26238958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
    Weir MR; Bakris GL; Gross C; Mayo MR; Garza D; Stasiv Y; Yuan J; Berman L; Williams GH
    Kidney Int; 2016 Sep; 90(3):696-704. PubMed ID: 27350174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bootstrap vs asymptotic variance estimation when using propensity score weighting with continuous and binary outcomes.
    Austin PC
    Stat Med; 2022 Sep; 41(22):4426-4443. PubMed ID: 35841200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I error rates, coverage of confidence intervals, and variance estimation in propensity-score matched analyses.
    Austin PC
    Int J Biostat; 2009 Apr; 5(1):Article 13. PubMed ID: 20949126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propensity score weighting analysis and treatment effect discovery.
    Mao H; Li L; Greene T
    Stat Methods Med Res; 2019 Aug; 28(8):2439-2454. PubMed ID: 29921162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The performance of inverse probability of treatment weighting and full matching on the propensity score in the presence of model misspecification when estimating the effect of treatment on survival outcomes.
    Austin PC; Stuart EA
    Stat Methods Med Res; 2017 Aug; 26(4):1654-1670. PubMed ID: 25934643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On variance estimation of target population created by inverse probability weighting.
    Chen J; Chen R; Feng Y; Tan M; Chen P; Wu Y
    J Biopharm Stat; 2023 Aug; ():1-19. PubMed ID: 37621147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On Variance of the Treatment Effect in the Treated When Estimated by Inverse Probability Weighting.
    Reifeis SA; Hudgens MG
    Am J Epidemiol; 2022 May; 191(6):1092-1097. PubMed ID: 35106534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing Extreme Propensity Scores via the Overlap Weights.
    Li F; Thomas LE; Li F
    Am J Epidemiol; 2019 Jan; 188(1):250-257. PubMed ID: 30189042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propensity score methods and regression adjustment for analysis of nonrandomized studies with health-related quality of life outcomes.
    Cottone F; Anota A; Bonnetain F; Collins GS; Efficace F
    Pharmacoepidemiol Drug Saf; 2019 May; 28(5):690-699. PubMed ID: 30784132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.